{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-26-000167","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2026-06-12T12:05:33+00:00","discovered_at":"2026-06-12T12:10:00.413028+00:00","generated_at":"2026-06-12T12:10:11.897098+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"McKesson subsidiary adds $2.25B senior secured term loan facility due 2032","bullets":["Amendment to April 1, 2026 Credit Agreement creates $2.25B Term B Loan Facility maturing 2032.","Borrower is McKesson Medical-Surgical Top Holdings, Inc.; interest at SOFR + 2.25% or Base Rate + 1.25%.","Initial interest rate selected is Adjusted Term SOFR plus 2.25% per annum.","Obligations secured by substantially all tangible/intangible assets of borrower and certain U.S. subsidiaries.","Facility subject to maximum total net leverage ratio and minimum interest coverage ratio covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-26-000167","json":"https://secwatch.observer/filing/0000927653-26-000167.json","markdown":"https://secwatch.observer/filing/0000927653-26-000167.md","text":"https://secwatch.observer/filing/0000927653-26-000167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765326000167/0000927653-26-000167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765326000167/mck-20260609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T12:10:11.897098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac817330f129ae5e62842a71365091145877574a","claim":"MCKESSON CORP incurred term loan of $2,250.0 million with JPMorgan Chase Bank, N.A. as administrative agent and collateral agent at Adjusted Term SOFR Rate plus 2.25% per annum or Base Rate plus 1.25% per annum maturing due 2032.","evidence_excerpt":"On June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into an amendment (the “Amendment”) to the Credit Agreement , dated as of April 1, 2026, among, the Borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as so amended, the “Credit Agreement”), to provide for a $2,250.0 million senior secured term “B” loan facility due 2032 (the “Term B Loan Facility”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000092765326000167/0000927653-26-000167-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$2,250.0 million"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A. as administrative agent and collateral agent"},{"label":"Rate","value":"Adjusted Term SOFR Rate plus 2.25% per annum or Base Rate plus 1.25% per annum"},{"label":"Maturity","value":"due 2032"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"c8c30f733a937f732374a134ee1cc562fde58aba","claim":"MCKESSON CORP amended Amendment to Credit Agreement, dated as of April 1, 2026 with JPMorgan Chase Bank, N.A. (as administrative agent) and other lenders valued at Term B loan facility of $2,250.0 million, interest at Adjusted Term SOFR + 2.25% or Base Rate + 1.25 (effective 2026-06-09).","evidence_excerpt":"On June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into an amendment (the “Amendment”) to the Credit Agreement , dated as of April 1, 2026, among, the Borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as so amended, the “Credit Agreement”), to provide for a $2,250.0 million senior secured term “B” loan facility due 2032 (the “Term B Loan Facility”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000092765326000167/0000927653-26-000167-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A. (as administrative agent) and other lenders"},{"label":"Value","value":"Term B loan facility of $2,250.0 million, interest at Adjusted Term SOFR + 2.25% or Base Rate + 1.25"},{"label":"Effective","value":"2026-06-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}